Advances in basic research, clinical diagnosis and treatment of thyroid cancer in 2022

Thyroid cancer is a common malignancy of the endocrine system with a significantly increased incidence in recent years. Surgical treatment is the primary treatment, followed by endocrine therapy and radionuclide therapy according to the clinical evaluations, and in some cases, radiotherapy and targe...

Full description

Saved in:
Bibliographic Details
Published inZhongguo ai zheng za zhi Vol. 33; no. 5; pp. 423 - 430
Main Author QU Ning, WANG Yuting, MA Ben, WANG Yu
Format Journal Article
LanguageEnglish
Published Editorial Office of China Oncology 01.05.2023
Subjects
thyroid cancer|epidemiology|basic research|clinical research|progress
Online AccessGet full text

Cover

More Information
Summary:Thyroid cancer is a common malignancy of the endocrine system with a significantly increased incidence in recent years. Surgical treatment is the primary treatment, followed by endocrine therapy and radionuclide therapy according to the clinical evaluations, and in some cases, radiotherapy and targeted therapy are needed. However, the mortality of thyroid cancer also tends to increase, especially in advanced or low/dedifferentiated patients with poor prognosis and short survival time. With the advancement of basic and clinical research, new progress has been made in individualized treatment of thyroid cancer. This article reviewed the research progress of thyroid cancer in 2022.
ISSN:1007-3639
DOI:10.19401/j.cnki.1007-3639.2023.05.001